新闻中心

News Center

Home page

All Categories



Company News

Industry News

The company held the product training meeting of Oran

Release Time

2022-06-22 11:09

On December 7, 2013, the company held a product training meeting of Oran at Daysun Lichi International Hotel in Guangzhou. The product training meeting invited Dr. Amit, the global medical director of Dr. Reddy Laboratories Co., Ltd., India to give an explanation. Dr. Ruidi's chief representative in China, Mr. Scheis, and the director of government affairs, Mr. Peng Huiming, were invited to receive the training. All employees of the company's marketing department, managers of various sales departments, and Oran from Guangdong, Beijing, Shanghai, Shandong and Sichuan were invited to receive the training. customers and related personnel of the marketing department. Dr. Amit gave a 3-hour explanation on the disease knowledge of schizophrenia, the knowledge of anti-schizophrenia drugs, and the product knowledge of Oranzhi. During the training, everyone actively asked questions and spoke, and had heated discussions and communication with medical experts, which achieved a very good training effect, allowing everyone to have a deeper and clearer understanding and understanding of mental illness and Oran. The promotion of Lanzhi has laid a solid foundation.

The company held the product launch of Oran

The company participated in the 70th (Guangzhou) National Pharmaceutical Fair

The company held the product launch of Oran

The company participated in the 70th (Guangzhou) National Pharmaceutical Fair

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

0755-82873500

Room 1502-1506, Building D2, Nanshan iPark, No.1001 Xue Yuan Boulevard, Nanshan District, Shenzhen, China.

0755-82873510

京ICP备10002622号-38

0755-82873500

0755-82873510